googlemarker

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 414628.98 Face Value (Rs.) : 1 House : Aurobindo
BSE707.70-5.4 (-0.76 %)
PREV CLOSE (Rs.) 713.10
OPEN PRICE (Rs.) 718.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 333954
TODAY'S LOW / HIGH (Rs.)705.00 723.50
52 WK LOW / HIGH (Rs.)504 808.95
NSE708.80-4.4 (-0.62 %)
PREV CLOSE( Rs. ) 713.20
OPEN PRICE (Rs.) 719.45
BID PRICE (QTY) 708.80 (40)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1479177
TODAY'S LOW / HIGH(Rs.) 706.75 722.85
52 WK LOW / HIGH (Rs.)503.05 809.45
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
2404.35
Dividend Yield(%)
0.35
TTM EPS (Rs.)
33.40
P/E Ratio
21.19
Book Value (Rs.)
160.53
Face Value (Rs.)
1
MCap (Rs. in Mn)
414628.98
Price/Earning (TTM)
18.23
Price/Sales (TTM)
4.17
Price/Book (MRQ)
4.41
PAT Margin (%)
17.45
ROCE (%)
19.75
Incorporation Year : 26-12 1986

Management Info :

K Ragunathan - Chairman N Govindarajan - Managing Director

Registered Office :

Address : Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone : +91-040-66725000

Website : www.aurobindo.com

Registrars Details :

Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
16Nov Aurobindo Pharma informs about investo
Aurobindo Pharma has informed that the Company is participating in inves..
13Nov Meeting Updates
Dilution of Company's ownership in subsidiary, Raidurgam Developers Ltd.
10Nov Fixes Record Date for Interim Dividend
Aurobindo Pharma Ltd has informed BSE that the Company has fixed Novembe..
QTR Sep 17 ANNUAL 17
Net Profit7528.317067.6
Gross Profit 9664.4 21785.7
Operating Profit 10680.7 25099
Net Sales 30738.6 97812.1
Rs. in Millions
Abbott India (BSE)
img  4942.00 (1.53%)
M.Cap (Rs. in Cr)10501.41
Ajanta Pharma (BSE)
img  1271.70 (4.03%)
M.Cap (Rs. in Cr)11192.80
Zandu Realty (BSE)
img  1340.10 (2.67%)
M.Cap (Rs. in Cr)108.07
Piramal Enterprises (BSE)
img  2604.60 (1.13%)
M.Cap (Rs. in Cr)44945.79
PROMOTERS
51.87%
MUTUAL FUNDS/UTI
14.89%
NON-INSTITUTION
13.98%
FI/BANKS/INSURANCE
0.46%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • SATCO CAPITAL MARKETS LTD. All rights reserved. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     377114